Long-Term Steroid Use Linked to Heart Damage and Premature Death, Study Warns

Background: A Growing Concern Over Anabolic Steroids

Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone that have legitimate medical uses, such as treating hormonal deficiencies and wasting diseases. However, they are far more widely known for their non-medical use, particularly among bodybuilders and athletes who take supraphysiological doses to accelerate muscle growth and enhance physical performance. While the strength-building effects are well established, the long-term health consequences of sustained AAS use have long been a subject of concern for cardiologists and public health experts. Many previous studies were limited by small sample sizes or short follow-up periods, leaving a gap in understanding about what happens to the heart after years of exposure. The new research directly addresses this gap and delivers a stark warning.

What the Study Revealed

The study, which drew on health records and cardiovascular imaging from hundreds of men with a history of prolonged AAS use, found that those who used the drugs for more than two years had significantly higher rates of heart structural abnormalities compared to non-users. These abnormalities included thickening of the left ventricle, reduced ventricular function, and higher prevalence of coronary artery plaque. Perhaps most concerning, the long-term users exhibited a markedly increased risk of heart failure and premature death when followed for over a decade. The researchers reported that chronic users had more than twice the risk of cardiovascular-related mortality compared to matched controls. The findings held even after adjusting for age, smoking, blood pressure, and underlying health conditions, suggesting the steroid exposure itself was a primary driver.

The imaging data were particularly telling. Ultrasound and cardiac MRI assessments showed that long-term users often had a reduced ejection fraction — a measure of the heart's pumping ability — and increased myocardial fibrosis, or scarring of heart tissue. These changes are characteristic of early-onset cardiomyopathy, a condition that progressively weakens the heart and can lead to fatal arrhythmias. Interestingly, some users in the study who had stopped taking steroids several years earlier still showed residual cardiac damage, indicating that the effects may not be fully reversible.

Expert Analysis: A Persistent and Often Hidden Risk

The researchers emphasized that many AAS users are young, healthy-looking men who may not perceive themselves as being at risk for cardiovascular disease. The lead investigator said in a statement that these findings should prompt clinicians to ask about steroid use in routine cardiovascular assessments, particularly among athletic patients presenting with unexplained symptoms such as shortness of breath, palpitations, or chest pain. An accompanying editorial described the results as "a sobering reminder that the pursuit of physical perfection can come at the cost of cardiovascular integrity." Cardiologists not involved in the study echoed this sentiment, urging that education efforts be directed not just at professional athletes but at recreational gym-goers, where AAS use has become increasingly common.

The study also highlighted the difficulty of identifying AAS use in clinical practice. Because anabolic steroids are often obtained illegally and used in cycles, patients may be reluctant to disclose their use. The authors recommended that physicians maintain a high index of suspicion when examining patients with unusually rapid muscle development or unexplained cardiac symptoms. They also called for better research into interventions that could limit or reverse steroid-induced heart damage, as current treatment strategies are largely supportive rather than curative.

Broader Context: The Rise of Aesthetic-Driven Steroid Use

While performance-enhancing drugs have been associated with elite sport for decades, the modern landscape extends far beyond the Olympic podium. Social media and fitness culture have fueled a surge in the aesthetic use of anabolic steroids, where the goal is not necessarily athletic performance but a muscular, lean physique. Surveys suggest that a significant proportion of gym attendees have experimented with these substances, and the age of first use has been dropping. This trend is especially worrying because the cardiovascular system is still developing in adolescents, and early exposure to exogenous testosterone may disrupt normal cardiac maturation. Endocrine researchers have also pointed to the broad range of physiological harm caused by AAS, including liver toxicity, dyslipidemia, and suppression of the body's natural testosterone production, which further complicates the patient management picture.

Implications for Clinical Practice and Public Policy

The study's implications are two-fold. For clinicians, it reinforces the need to consider AAS as a potential cause of heart disease in young and middle-aged men who otherwise lack traditional risk factors. The authors suggest that cardiac screening, including echocardiography and possibly cardiac MRI, should be considered for anyone with a history of prolonged AAS use. For public health authorities, the results add weight to the argument for stronger regulation of illegal steroid distribution and targeted educational campaigns aimed at de-glamorizing these drugs. Several countries have already launched awareness initiatives, but funding for them has often been insufficient. The researchers note that the burden of disease caused by AAS is likely underestimated, because many users do not seek medical attention until serious symptoms emerge, and some die suddenly without ever having a formal diagnosis of steroid-induced cardiac pathology.

What's Next: A Call for Longitudinal Research and Reversibility Studies

Moving forward, the research team plans to expand the study to include a larger and more diverse cohort, including women, who also use anabolic steroids but remain seriously understudied. Another key area of investigation is whether the structural changes observed in the heart can be reversed after discontinuation of steroid use. Although the current data suggest residual damage persists, small studies have hinted that some parameters, such as left ventricular thickness, may improve over time in those who remain abstinent. The authors hope to identify biomarkers that could predict which users are at highest risk of developing heart failure, enabling earlier interventions. There is also interest in exploring whether commonly used cardiovascular medications, such as ACE inhibitors or beta-blockers, could help mitigate the progression of cardiac damage in individuals who choose to continue using steroids.

In the meantime, the public health message is clear: long-term steroid use is not a benign lifestyle choice. It carries serious, potentially irreversible consequences for the heart and the life of the user. For physicians, the study is a call to action to routinely ask about anabolic steroid use and to take those disclosures seriously. For the millions of individuals considering or currently using these drugs, the evidence now shows that the muscle built through steroids may be far less durable than the damage left behind.